Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.

Richard C. Breeden net worth and biography

Richard Breeden Biography and Net Worth

Director of STERIS

Richard C. Breeden director since April 2008, and Chairman and Chief Executive Officer of Breeden Capital Management LLC since 2005. Since 1996 he has also been Chairman of Richard C. Breeden & Co., LLC, a professional services firm providing consulting services. From time to time Mr. Breeden also handles asset distributions to victims of unlawful conduct, typically on behalf of U.S. Government agencies. Since late 2012, Mr. Breeden has served as Special Master on behalf of the U.S. Department of Justice to administer and distribute just over $4 billion in forfeited assets to victims of the fraud at Madoff Securities through the Madoff Victim Fund. Mr. Breeden has previously handled asset distributions to victims of unlawful conduct at WorldCom, Enron, Adelphia, Royal Dutch Shell, British Petroleum, JPMorgan Chase, and other companies. Mr. Breeden served as Chairman of the SEC from 1989 to 1993.

What is Richard C. Breeden's net worth?: The estimated net worth of Richard C. Breeden is at least $7.33 million as of August 24th, 2020. Mr. Breeden owns 31,681 shares of STERIS stock worth more than $7,328,766 as of May 11th. This net worth approximation does not reflect any other investments that Mr. Breeden may own. Learn More about Richard C. Breeden's net worth.
How do I contact Richard C. Breeden?: The corporate mailing address for Mr. Breeden and other STERIS executives is 70 Sir John Rogerson`s Quay, Dublin L2, D02 R296. STERIS can also be reached via phone at (440) 354-2600 and via email at [email protected]. Learn More on Richard C. Breeden's contact information.
Has Richard C. Breeden been buying or selling shares of STERIS?: Richard C. Breeden has not been actively trading shares of STERIS during the past quarter. Most recently, Richard C. Breeden sold 25,000 shares of the business's stock in a transaction on Monday, August 24th. The shares were sold at an average price of $152.67, for a transaction totalling $3,816,750.00. Following the completion of the sale, the director now directly owns 31,681 shares of the company's stock, valued at $4,836,738.27. Learn More on Richard C. Breeden's trading history.
Who are STERIS's active insiders?: STERIS's insider roster includes Richard Breeden (Director), Karen Burton (CAO), Daniel Carestio (SVP), Cynthia Feldmann (Director), Jacqueline Kosecoff (Director), David Lewis (Director), Julia Madsen (VP), Cary Majors (SVP), Walter Rosenbrough, Jr. (CEO), Mohsen Sohi (Director), Renato Tamaro (VP), Michael Tokich (CFO), and John Zangerle (VP). Learn More on STERIS's active insiders.
Are insiders buying or selling shares of STERIS?: In the last twelve months, insiders at the medical equipment provider sold shares 1 times. They sold a total of 2,069 shares worth more than $439,207.32. The most recent insider tranaction occured on May, 15th when Director Mohsen Sohi sold 2,069 shares worth more than $439,207.32. Insiders at STERIS own 1.0% of the company. Learn More about insider trades at STERIS.
Information on this page was last updated on 5/15/2023.

Richard C. Breeden Insider Trading History at STERIS

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/24/2020	Sell	25,000	$152.67	$3,816,750.00	31,681

Richard C. Breeden Buying and Selling Activity at STERIS

STERIS Company Overview

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. It also provides capital equipment installation, maintenance, upgradation, repair, and troubleshooting services; preventive maintenance programs and repair services; instrument and endoscope repair and maintenance services; and custom process improvement consulting and outsourced instrument sterile processing services. The Applied Sterilization Technologies segment provides contract sterilization and testing services for medical device and pharmaceutical manufacturers through a network of approximately 50 contract sterilization and laboratory facilities. The Life Sciences segment designs, manufactures and sells consumable products, such as formulated cleaning chemistries, barrier, sterility assurance products, steam and vaporized hydrogen peroxide sterilizers, and washer disinfectors. This segment also offers equipment installation, maintenance, upgradation, repair, and troubleshooting services; and preventive maintenance programs and repair services. The Dental segment provides hand and electric-powered dental instruments, infection control products, conscious sedation, personal protective equipment, and water quality products for dental suite. The company serves its products and services to hospitals, other healthcare providers, and pharmaceutical manufacturers. The company was founded in 1985 and is based in Dublin, Ireland.

Today's Range

Now: $231.33

$223.68

$231.74

50 Day Range

MA: $216.99

$198.94

$233.84

2 Week Range

Now: $231.33

$195.47

$254.00

Volume

867,834 shs

Average Volume

606,704 shs

Market Capitalization

$22.86 billion

P/E Ratio

60.56

Dividend Yield

0.92%

Beta

0.81

Claim Your Complimentary Bitcoin Reward

From Crypto Swap Profits | Ad

Secure Your Spot Now